Nguyen Stephanie, Dhedin Nathalie, Vernant Jean-Paul, Kuentz Mathieu, Al Jijakli Ahmad, Rouas-Freiss Nathalie, Carosella Edgardo D, Boudifa Ali, Debré Patrice, Vieillard Vincent
Laboratoire d'Immunologie Cellulaire et Tissulaire INSERM U543, Hôpital Pitié-Salpêtrière, 83 Bvd de l'Hôpital 75013 Paris, France.
Blood. 2005 May 15;105(10):4135-42. doi: 10.1182/blood-2004-10-4113. Epub 2005 Feb 1.
Natural killer (NK) cell alloreactivity is reported to mediate strong GvL (graft versus leukemia) effect in patients after haploidentical stem-cell transplantation (SCT) for acute myeloid leukemia (AML). Because subsequent immune reconstitution remains a major concern, we studied NK-cell recovery in 10 patients with AML who received haplomismatched SC transplants, among whom no GvL effect was observed, despite the mismatched immunoglobulin-like receptor (KIR) ligand in the GvH direction for 8 of 10 patients. NK cells generated after SCT exhibited an immature phenotype: the cytotoxic CD3- CD56(dim) subset was small, expression of KIRs and NKp30 was reduced, while CD94/NKG2A expression was increased. This phenotype was associated to in vitro lower levels of cytotoxicity against a K562 cell line and against primary mismatched AML blasts than donor samples. This impaired lysis was correlated with CD94/NKG2A expression in NK cells. Blockading CD94/NKG2A restored lysis against the AML blasts, which all expressed HLA-E, the ligand for CD94/NKG2A. Our present study allows a better understanding of the NK-cell differentiation after SCT. These results revealed that the NK cells generated after haplomismatched SCT are blocked at an immature state characterized by specific phenotypic features and impaired functioning, having potential impact for immune responsiveness and transplantation outcome.
据报道,自然杀伤(NK)细胞同种异体反应性可介导单倍体相合干细胞移植(SCT)治疗急性髓系白血病(AML)患者后的强烈移植物抗白血病(GvL)效应。由于后续的免疫重建仍然是一个主要问题,我们研究了10例接受单倍体不相合SC移植的AML患者的NK细胞恢复情况,其中10例患者中有8例在移植物抗宿主(GvH)方向存在不相合的免疫球蛋白样受体(KIR)配体,但未观察到GvL效应。SCT后产生的NK细胞表现出不成熟的表型:细胞毒性CD3-CD56(dim)亚群较小,KIRs和NKp30的表达降低,而CD94/NKG2A的表达增加。这种表型与体外对K562细胞系和原发性不相合AML原始细胞的细胞毒性水平低于供体样本有关。这种裂解受损与NK细胞中CD94/NKG2A的表达相关。阻断CD94/NKG2A可恢复对AML原始细胞的裂解,这些原始细胞均表达CD94/NKG2A的配体HLA-E。我们目前的研究有助于更好地理解SCT后NK细胞的分化。这些结果表明,单倍体不相合SCT后产生的NK细胞被阻滞在一种以特定表型特征和功能受损为特征的不成熟状态,这可能对免疫反应性和移植结果产生影响。